| Literature DB >> 36188835 |
Gerd F Volk1,2, Benjamin Roediger1, Katharina Geißler1,2, Anna-Maria Kuttenreich1,2, Carsten M Klingner2,3, Christian Dobel1,2, Orlando Guntinas-Lichius1,2.
Abstract
Background: There is no current standard for facial synkinesis rehabilitation programs. The benefit and stability of effect of an intensified 10-day facial training combining electromyography and visual biofeedback training was evaluated.Entities:
Keywords: biofeedback; electromyography; facial nerve paralysis; physical therapy; rehabilitation; synkinesis
Year: 2021 PMID: 36188835 PMCID: PMC9397686 DOI: 10.3389/fresc.2021.746188
Source DB: PubMed Journal: Front Rehabil Sci ISSN: 2673-6861
Figure 1Combined visual and EMG biofeedback setting. The patient (1) is sitting in front of a screen (2) showing himself via a camera on top of the screen. The therapist (3) is sitting in opposite to the patient allowing a direction view on patient's face. Beyond the face of the patient, the screen of the therapist (4) is showing the same information as the patient's screen: Bars are showing the surface EMG activity of the recorded muscles, in this examples the EMG activity is recorded symmetrically from both zygomatic muscles to control lifting the corner of the mouth on the affected side symmetrically to the contralateral side.
Figure 2Workflow of the examinations. T0 = day of the screening and inclusion into the training and the study. T1 = first day of the facial training. T2 = last day of the facial training (10th day). T3 = follow-up examination. Median interval between T0 and T1 (waiting period) was 4.4 months. Median interval between T2 and T3 (home training period) was 6 months.
Patients' characteristics.
|
|
|
|
|---|---|---|
| All | 54 | 100 |
|
| ||
| Female | 42 | 77.8 |
| Male | 12 | 22.2 |
|
| ||
| Left | 30 | 55.6 |
| Right | 24 | 44.4 |
|
| ||
| Idiopathic | 23 | 42.6 |
| traumatic/post-surgical | 18 | 33.3 |
| Inflammatory | 12 | 22.2 |
| Stroke, brainstem | 1 | 1.9 |
|
| ||
| Age, years, | 42.8 ± 1.5 | 49.5, 14–77 |
| Interval onset of facial palsy to training, months | 62.3 ± 66.9 | 31.1, 12–302 |
| Interval T0–T1 (waiting period), months | 4.8 ± 2.4 | 4.4, 0.7–10.5 |
| Interval, T2–T3 (follow-up period), months | 6.3 ± 1.3 | 6.0 ± 5.0–11.8 |
Comparison of facial grading at the initial screening (T1), start (T1), and end (T2) of therapy, and at follow-up (T3).
|
|
|
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| |
| House-Brackmann | 3.1 | 2.9–3.3 | 3.1 | 2.9–3.3 | 2.8 | 2.8–3.0 | 2.9 | 2.7–3.1 | 0.046; 0.29 | 0.156; 0.19 | |
| Stennert, rest | 1.4 | 1.2–1.6 | 1.4 | 1.1–1.6 | 1.2 | 1.0–1.4 | 1.2 | 1.0–1.4 | 0.532; 0.09 | 0.021; 0.46 | 0.766; 0.04 |
| Stennert, motion | 2.6 | 2.2–2.9 | 2.6 | 2.2–2.9 | 2.4 | 2.1–2.9 | 2.4 | 2.1–2.4 | 0.766; 0.77 | 0.485; 0.10 | |
| Stennert, total | 3.9 | 3.5–4.4 | 3.9 | 3.5–4.4 | 3.6 | 3.1–4.1 | 3.6 | 3.2–4.1 | 0.857; 0.04 | 0.007; 0.54 | 0.821; 0.03 |
| FNGS 2.0, brow | 4.4 | 3.9–4.9 | 4.4 | 4.0–4.9 | 4.3 | 3.8–4.7 | 4.4 | 3.9–4.8 | 0.010; 0.38 | 0.002; 0.64 | 0.058; 0.26 |
| FNGS 2.0, eye | 1.7 | 1.4–1.9 | 1.6 | 1.4–1.9 | 1.6 | 1.3–1.8 | 1.5 | 1.3–1.8 | 0.444; 0.11 | 0.160; 0.28 | 0.569; 0.08 |
| FNGS 2.0, NLF | 3.1 | 2.7–3.4 | 2.9 | 2.6–3.2 | 2.5 | 2.2–2.8 | 2.4 | 2.1–2.7 | 0.038; 0.30 | 0.419; 0.11 | |
| FNGS 2.0, oral | 2.2 | 2.0–2.4 | 2.2 | 2.0–2.4 | 1.9 | 1.7–2.1 | 1.9 | 1.7–2.1 | 0.766; 0.04 | 0.709; 0.05 | |
| FNGS 2.0, regional | 11.3 | 10.4–12.2 | 11.2 | 10.3–12.0 | 10.2 | 9.4–11.0 | 10.2 | 9.4–11.0 | 0.597; 0.08 | 0.830; 0.03 | |
| FNGS 2.0, synkinesis | 1.5 | 1.4–1.7 | 1.5 | 1.3–1.7 | 1.2 | 1.1–1.3 | 1.3 | 1.1–1.4 | 0.659; 0.06 | 0.419; 0.11 | |
| FNGS 2.0, total | 12.8 | 11.9–13.7 | 12.7 | 11.8–13.5 | 11.4 | 10.6–12.2 | 11.4 | 10.7–12.2 | 0.909; 0.02 | 0.569; 0.08 | |
| SFGS, resting symmetry | 9.4 | 7.9–10.9 | 9.6 | 8.2–11.1 | 8.5 | 7.2–9.9 | 8.4 | 7.0–9.8 | 0.799; 0.04 | 0.003; 0.60 | 0.821; 0.03 |
| SFGS, frontalis | 2.3 | 1.9–2.6 | 2.2 | 1.9–2.5 | 2.4 | 2.0–2.7 | 2.3 | 2.0–2.6 | 0.010; 0.38 | 0,005; 0.57 | 0.322; 0.14 |
| SFGS, orbicularis oculi | 4.4 | 4.2–4.7 | 4.4 | 4.2–4.7 | 4.5 | 4.3–4.7 | 4.5 | 4.3–4.7 | 07.85; 0.03 | 0.261; 0.22 | 0.569; 0.08 |
| SFGS, zygomaticus, risorius | 3.1 | 2.8–3.4 | 3.2 | 3.0–3.5 | 3.6 | 3.3–3.9 | 3.7 | 3.4–4.0 | 0.006; 0.40 | 0.013; 0.35 | |
| SFGS, levator labii superior | 3.1 | 2.8–3.4 | 3.2 | 3.0–3.5 | 3.6 | 3.3–3.9 | 3.6 | 3.3–3.9 | 0.051; 0.28 | 1.000; 0.00 | |
| SFGS, orbicularis oris | 3.9 | 3.7–4.1 | 3.9 | 3.7–4.1 | 4.4 | 4.0–4.4 | 4.2 | 4.1–4.4 | 0.532; 0.09 | 0.419; 0.11 | |
| SFGS, movement symmetry | 67.0 | 63.1–70.9 | 68.0 | 64.4–71.6 | 73.0 | 69.3–76.6 | 73.5 | 69.8–77.1 | 0.243; 0.16 | 0.212; 0.17 | |
| SFGS, synkinesis frontalis | 0.9 | 0.7–1.1 | 0.9 | 0.7–1.1 | 0.7 | 0.6–0.9 | 0.7 | 0.6–0.9 | 0.766; 0.04 | 0.021; 0.46 | 0.742; 0.05 |
| SFGS, synkinesis orbicularis oculi | 0.6 | 0.4–0.7 | 0.6 | 0.5–0.7 | 0.4 | 0.3–0.6 | 0.5 | 0.4–0.7 | 0.742; 0.05 | 0.003; 0.60 | 0.013; 0.35 |
| SFGS, synkinesis zygomaticus, risorius | 1.3 | 1.2–1.5 | 1.3 | 1.1–1.5 | 1.1 | 1.0–1.3 | 1.1 | 0.9–1.3 | 0.420; 0.12 | 0.021; 0.46 | 0.410; 0.11 |
| SFGS, synkinesis levator labii superior | 1.3 | 1.1–1.5 | 1.3 | 1.1–1.5 | 1.0 | 0.9–1.3 | 1.0 | 0.8–1.2 | 0.322; 0.14 | 0.532; 0.09 | |
| SFGS, synkinesis orbicularis oris | 1.0 | 0.7–1.2 | 0.9 | 0.7–1.2 | 0.5 | 0.3–0.7 | 0.5 | 0.4–0.7 | 0.532; 0.09 | 0.485; 0.10 | |
| SFGS, synkinesis | 5.1 | 4.4–5.8 | 5.0 | 4.4–5.6 | 3.8 | 3.3–4.4 | 3.9 | 3.3–4.4 | 0.424; 0.11 | 0.808; 0.03 | |
| SFGS, composite | 52.5 | 48.1–56.9 | 53.4 | 49.2–56.6 | 60.6 | 56.5–64.7 | 61.2 | 57.0–65.4 | 0.520; 0.13 | 0.322; 0.13 |
Significant/strong effects in bold; FNGS 2.0, Facial Nerve Grading System 2.0; NLF, nasolabial fold; SFGS, Sunnybrook Facial Grading System.
Figure 3Changes of the facial grading from T0 to T3 using the Sunnybrook grading scale and its subscores. (A) Symmetry of the face at rest. (B) Symmetry of voluntary movements. (C) Synkinesis. (D) Composite score. Significant changes (*p ≤ 0.001) are only seen between T1 and T2 as a training effect, except for symmetry at rest.